Yixintang Pharmaceutical (SZ:002727)2025-10-31 10:52Group 1: Investor Relations Activities - The investor relations activity was categorized as an analyst meeting, with a total of 51 participants from various securities firms [2] - The meeting took place on October 31, 2025, from 15:30 to 16:30 at the headquarters of Yixin Tang Pharmaceutical Group [2] - Key company representatives included Vice President and Board Secretary Mr. Li Zhenghong and Financial Officer Mr. Xiao Donglei [2] Group 2: Participants - Notable participants included analysts from Northeast Securities, CITIC Securities, and UBS, among others [3] - A total of 51 investors attended, representing a diverse range of financial institutions [2][3] Group 3: Meeting Purpose - The primary focus of the meeting was the discussion of the Q3 2025 financial results of Yixin Tang Pharmaceutical [2] - The meeting served as a platform for investors to gain insights into the company's performance and future outlook [2]